The global fluoroscopy market size is estimated to be growing at a CAGR of 3.2% during the forecast period. The size of the market is estimated to value USD 2403.9 million by 2026 from USD 2053.6 million in 2021.
Fluoroscopy is an imaging technique primarily used for the imaging of the gastrointestinal tract to analyze clinical conditions. X-rays are used in this fluoroscopy to allow real-time images of internal organs. By this fluoroscopy, clinical conditions like a tumor, ulcers, irritation, etc., can be analyzed. The fluoroscopy captures live moving pictures of internal organs, which can be seen on the screen or television-like monitor. It is also used to screen the methods like angiography, venography, orthopedic surgeries, and situation of peritoneal catheters, individual biopsies, and many distinct surgical techniques that need radiological medication. Fluoroscopy decreases the hospital stay period, and it has a low risk to the patients. Moreover, it helps in locating foreign bodies, image-guided anesthetic injections, percutaneous vertebroplasty, etc.
MARKET DRIVERS:
The global fluoroscopy market is expected to grow significantly during the forecast period due to the tie-ups amongst industrialists and manufacturers of medical devices. A limitless range of utilization and high demand for infrastructure in the healthcare industry in developing and underdeveloped nations are driving the worldwide fluoroscopes market. The expansion in the utilization of refurbished devices, alongside a low substitution rate of fluoroscopes, is hindering the development of the worldwide fluoroscopes market.
The global fluoroscopy market growth is further driven by the increase in aging population all around the world and rising demand for minimally invasive interventional procedures. Moreover, the increase in orthopedic surgeries, cardiovascular diseases, and a boundless range of utilization is fueling the market. The rise in road accidents all over the world every year is propelling the growth of the global fluoroscopy market.
The growing demand for infrastructure in the healthcare industry in emerging and undeveloped nations and the rise in awareness of the fluoroscopy process are further driving the market. The growth in the investments in R&D by governments and private organizations is supposed to fuel the Fluoroscopy Market in forthcoming years.
MARKET RESTRAINTS:
The fluoroscopy procedures have a high risk of radiation exposure which restrains the global market growth. The high cost associated with the fluoroscopy equipment and a low substitution rate of fluoroscopes are hindering the global market growth. Moreover, the expansion in the utilization of refurbished devices is limiting the market growth.
The new players in the market may suffer from the high initial investment, and engineering cost and multidisciplinary product development teams need are the major challenges for the fluoroscopy market growth in the coming years.
Impact of COVID-19 on the global fluoroscopy market:
The COVID has impacted the global economy very badly. The World Health Organisation (WHO) has announced the COVID as a pandemic in March 2020. As the novel coronavirus disease spread at a rapid pace, all the countries have announced strict lockdown guidelines in the first half of 2020. The lockdown is the main suspect for the demolishing of the global economy. Due to lockdown, all the industries or sectors had gone through rough times. The Fluoroscopy Market has also been affected due to this virus. Due to limited manufacturing industries' limited workers, the output of the Fluoroscopy devices got rapidly decreased, which involved the market growth. The market players claimed that the clinics and scanning centers had reduced buying the devices due to coronavirus. For instance, in India, private hospitals had faced 90% losses during the pandemic. Moreover, the supply system's disturbance due to strict lockdown implementation and delay in after-sales services had hindered the market.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Surgery Type, End User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This research report on the global fluoroscopy market has been segmented and sub-segmented into the following categories and analysed market size and forecast for each segment until 2025.
Fluoroscopy Market - By Surgery Type:
On the basis of surgery type, cardiovascular interventions are expected to overwhelm the worldwide fluoroscopy market during the forecast period. The high demand for the equipment in cardiovascular is boosting the market. Moreover, the increase of awareness in the people and advancements in technology pushes the cardiovascular interventions segment. The orthopedic surgery segment is predominantly growing during the forecast period. The rise in orthopedic surgeries due to increasing incidences of road accidents is propelling the segment growth.
Fluoroscopy Market - By End User:
On the basis of End-User, the hospital's segment had the highest shares in the end-user segment during the forecast period. The rise inpatient admissions led to the hospital segment. The increase in government investments in R&D to improve efficiency is boosting the market. For example, the United States FDA took a step to decrease and optimize medical imaging radiation exposure, which helped the hospital segment grow.
Fluoroscopy Market - By Region:
Geographically, North America is projected to lead the global fluoroscopy market during the forecast period. The market size was worth USD 756.49 million in 2020 and is expected to be growing at a CAGR of 2.80% to reach 868.5 billion by 2025. The rising incidents of cardiovascular diseases in North America had led to the market leader. The presence of a humongous number of elderly people and well-established healthcare infrastructure is fueling the North American market. The critical market contributors, according to the countries in North America, are the US and Canada. The increase in heart diseases in the United States is propelling the market growth. For instance, according to the Center for Disease Control and Prevention (CDC), more than 647,000 Americans die from heart disease every year, and for every 37 seconds, one person dies from cardiovascular disease. The presence of a high number of market players is boosting North America's, Fluoroscopy Market.
The Asia Pacific accounted for the second-largest share in the Fluoroscopy Market. The market is estimated to register USD 318.4 million in 2020; and is anticipated to be growing at a CAGR of 4.20%, to reach USD 391.12 million by 2025. The market in the rising economies of Asia-Pacific is driving the market. The increase in the adoption of fluoroscopy techniques in hospitals and the rise in awareness among people boost the Asia Pacific market growth. India, China, and Japan are the major market contributors to the Asia Pacific region. An increase in road accidents and the presence of a high population are the significant factors that are boosting the Asia Pacific Fluoroscopy Market.
KEY MARKET PARTICIPANTS:
Companies leading the global fluoroscopy market profiled in the report are GE Healthcare., Orthoscan Inc., Hologic Inc., Shimadzu Corporation, Siemens Medical Solutions, Philips N.V., Hitachi Ltd., Toshiba Medical Systems Corporation, Ziehm Imaging GmbH and Amico X-ray innovations.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Fixed systems
5.1.3 Bio systems
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2 Application 5.2.1 Introduction
5.2.2 Biopsy
5.2.3 Cardiovascularmediations
5.2.4 Orthopedic surgeries
5.3.5 Other Applications
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.3 End User 5.3.1 Introduction
5.3.2 Clinics
5.3.3 Hospitals
5.3.4 Diagnostic centers
5.4.7 Y-o-Y Growth Analysis, By End Users
5.4.8 Market Attractiveness Analysis, By End Users
5.4.9 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis 6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis 6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.1.5.4 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Orthoscan Inc
8.3Hologic Inc
8.4 Shimadzu Corporation
8.5 Siemens Medical Solutions
8.6 Philips N.V
8.7 Hitachi Ltd
8.8 Toshiba Medical Systems Corporation
8.9 Ziehm Imaging GmbH
8.10 Amico X-ray innovations
8.11 Carestream Health
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
Apr 2021
